106 related articles for article (PubMed ID: 23808164)
21. DNA methylation status of hMLH1, p16(INK4a), and CDH1 is not associated with mRNA expression levels of DNA methyltransferase and DNA demethylase in gastric carcinomas.
Oue N; Kuraoka K; Kuniyasu H; Yokozaki H; Wakikawa A; Matsusaki K; Yasui W
Oncol Rep; 2001; 8(5):1085-9. PubMed ID: 11496321
[TBL] [Abstract][Full Text] [Related]
22. [Characteristics of complex formation between monomeric and dimeric bisbenzimidazoles and AT-containing polynucleotide].
Lisitsina ES; Durandin NA; Ivanov AA; Strel'tsov SA; Susova OIu; Shtil' AA; Zhuze AL; Kuz'min VA
Mol Biol (Mosk); 2012; 46(6):922-7. PubMed ID: 23350239
[TBL] [Abstract][Full Text] [Related]
23. Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation.
Jüttermann R; Li E; Jaenisch R
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):11797-801. PubMed ID: 7527544
[TBL] [Abstract][Full Text] [Related]
24. DNA methyltransferases: emerging targets for the discovery of inhibitors as potent anticancer drugs.
Yu J; Xie T; Wang Z; Wang X; Zeng S; Kang Y; Hou T
Drug Discov Today; 2019 Dec; 24(12):2323-2331. PubMed ID: 31494187
[TBL] [Abstract][Full Text] [Related]
25. DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells.
Kim H; Park J; Jung Y; Song SH; Han SW; Oh DY; Im SA; Bang YJ; Kim TY
Int J Oncol; 2010 Jun; 36(6):1563-72. PubMed ID: 20428781
[TBL] [Abstract][Full Text] [Related]
26. DNA specific fluorescent symmetric dimeric bisbenzimidazoles DBP(n): the synthesis, spectral properties, and biological activity.
Ivanov AA; Koval VS; Susova OY; Salyanov VI; Oleinikov VA; Stomakhin AA; Shalginskikh NA; Kvasha MA; Kirsanova OV; Gromova ES; Zhuze AL
Bioorg Med Chem Lett; 2015 Jul; 25(13):2634-8. PubMed ID: 25987376
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of murine DNA methyltransferase Dnmt3a by DNA duplexes containing pyrimidine-2(1H)-one.
Cherepanova NA; Zhuze AL; Gromova ES
Biochemistry (Mosc); 2010 Sep; 75(9):1115-25. PubMed ID: 21077830
[TBL] [Abstract][Full Text] [Related]
28. The role of DNA methylation in the pathogenesis and treatment of cancer.
Peedicayil J
Curr Clin Pharmacol; 2012 Nov; 7(4):333-40. PubMed ID: 22794162
[TBL] [Abstract][Full Text] [Related]
29. PRIMA-1 selectively induces global DNA demethylation in p53 mutant-type thyroid cancer cells.
Qiang W; Jin T; Yang Q; Liu W; Liu S; Ji M; He N; Chen C; Shi B; Hou P
J Biomed Nanotechnol; 2014 Jul; 10(7):1249-58. PubMed ID: 24804545
[TBL] [Abstract][Full Text] [Related]
30. 5-Aza-2'-deoxycytidine, a DNA methylation inhibitor, induces cytotoxicity, cell cycle dynamics and alters expression of DNA methyltransferase 1 and 3A in mouse hippocampus-derived neuronal HT22 cells.
Yang J; Tian X; Yang J; Cui J; Jiang S; Shi R; Liu Y; Liu X; Xu W; Xie W; Jia X; Bade R; Zhang T; Zhang M; Gong K; Yan S; Yang Z; Shao G
J Toxicol Environ Health A; 2017; 80(22):1222-1229. PubMed ID: 28880816
[TBL] [Abstract][Full Text] [Related]
31. Rational Design of Bisubstrate-Type Analogues as Inhibitors of DNA Methyltransferases in Cancer Cells.
Halby L; Menon Y; Rilova E; Pechalrieu D; Masson V; Faux C; Bouhlel MA; David-Cordonnier MH; Novosad N; Aussagues Y; Samson A; Lacroix L; Ausseil F; Fleury L; Guianvarc'h D; Ferroud C; Arimondo PB
J Med Chem; 2017 Jun; 60(11):4665-4679. PubMed ID: 28463515
[TBL] [Abstract][Full Text] [Related]
32. DNA methyltransferase inhibitors-state of the art.
Goffin J; Eisenhauer E
Ann Oncol; 2002 Nov; 13(11):1699-716. PubMed ID: 12419742
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy.
Gowher H; Jeltsch A
Cancer Biol Ther; 2004 Nov; 3(11):1062-8. PubMed ID: 15539938
[TBL] [Abstract][Full Text] [Related]
34. The effect of acute dichlorodiphenyltrichloroethane exposure on hypermethylation status and down-regulation of p53 and p16INK4a genes in rat liver.
Kostka G; Urbanek-Olejnik K; Liszewska M; Winczura A
Environ Toxicol; 2016 May; 31(5):584-92. PubMed ID: 25410620
[TBL] [Abstract][Full Text] [Related]
35. The effects of the DNA methyltranfserases inhibitor 5-Azacitidine on ageing, oxidative stress and DNA methylation of adipose derived stem cells.
Kornicka K; Marycz K; Marędziak M; Tomaszewski KA; Nicpoń J
J Cell Mol Med; 2017 Feb; 21(2):387-401. PubMed ID: 27998022
[TBL] [Abstract][Full Text] [Related]
36. Development of DNA methyltransferase inhibitors for the treatment of neoplastic diseases.
Fandy TE
Curr Med Chem; 2009; 16(17):2075-85. PubMed ID: 19519382
[TBL] [Abstract][Full Text] [Related]
37. Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cells.
Graça I; Sousa EJ; Baptista T; Almeida M; Ramalho-Carvalho J; Palmeira C; Henrique R; Jerónimo C
Curr Pharm Des; 2014; 20(11):1803-11. PubMed ID: 23888969
[TBL] [Abstract][Full Text] [Related]
38. Impact of Dnmt1 deficiency, with and without low folate diets, on tumor numbers and DNA methylation in Min mice.
Trasler J; Deng L; Melnyk S; Pogribny I; Hiou-Tim F; Sibani S; Oakes C; Li E; James SJ; Rozen R
Carcinogenesis; 2003 Jan; 24(1):39-45. PubMed ID: 12538347
[TBL] [Abstract][Full Text] [Related]
39. 5-Aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45- and p53-dependent mechanisms.
Schneider-Stock R; Diab-Assef M; Rohrbeck A; Foltzer-Jourdainne C; Boltze C; Hartig R; Schönfeld P; Roessner A; Gali-Muhtasib H
J Pharmacol Exp Ther; 2005 Feb; 312(2):525-36. PubMed ID: 15547111
[TBL] [Abstract][Full Text] [Related]
40. DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge.
Castillo-Aguilera O; Depreux P; Halby L; Arimondo PB; Goossens L
Biomolecules; 2017 Jan; 7(1):. PubMed ID: 28067760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
